516 related articles for article (PubMed ID: 32680541)
1. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature.
Igboeli P; El Andaloussi A; Sheikh U; Takala H; ElSharoud A; McHugh A; Gavrilova-Jordan L; Levy S; Al-Hendy A
J Med Case Rep; 2020 Jul; 14(1):108. PubMed ID: 32680541
[TBL] [Abstract][Full Text] [Related]
2. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model.
Park HS; Chugh RM; Elsharoud A; Ulin M; Esfandyari S; Aboalsoud A; Bakir L; Al-Hendy A
Cell Transplant; 2021; 30():963689720988502. PubMed ID: 33593078
[TBL] [Abstract][Full Text] [Related]
3. Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure.
Mohamed SA; Shalaby SM; Abdelaziz M; Brakta S; Hill WD; Ismail N; Al-Hendy A
Reprod Sci; 2018 Jan; 25(1):51-63. PubMed ID: 28460567
[TBL] [Abstract][Full Text] [Related]
4. Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model.
Park HS; Seok J; Cetin E; Ghasroldasht MM; Liakath Ali F; Mohammed H; Alkelani H; Al-Hendy A
Am J Obstet Gynecol; 2024 Jul; 231(1):111.e1-111.e18. PubMed ID: 38378099
[TBL] [Abstract][Full Text] [Related]
5. Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure.
Chen X; Wang Q; Li X; Wang Q; Xie J; Fu X
Stem Cell Res Ther; 2018 Sep; 9(1):240. PubMed ID: 30257708
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human.
Mashayekhi M; Mirzadeh E; Chekini Z; Ahmadi F; Eftekhari-Yazdi P; Vesali S; Madani T; Aghdami N
J Ovarian Res; 2021 Jan; 14(1):5. PubMed ID: 33407794
[TBL] [Abstract][Full Text] [Related]
7. Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells in Women with Premature Ovarian Failure.
Zafardoust S; Kazemnejad S; Darzi M; Fathi-Kazerooni M; Saffarian Z; Khalili N; Edalatkhah H; Mirzadegan E; Khorasani S
Arch Med Res; 2023 Feb; 54(2):135-144. PubMed ID: 36702667
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure.
Bahrehbar K; Rezazadeh Valojerdi M; Esfandiari F; Fathi R; Hassani SN; Baharvand H
World J Stem Cells; 2020 Aug; 12(8):857-878. PubMed ID: 32952863
[TBL] [Abstract][Full Text] [Related]
9. Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice.
Nabil Salama A; Badr EAE; Holah NS; El Barbary AA; Hessien M
Reprod Sci; 2024 Apr; 31(4):1053-1068. PubMed ID: 37957472
[TBL] [Abstract][Full Text] [Related]
10. Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats.
Liu J; Zhang H; Zhang Y; Li N; Wen Y; Cao F; Ai H; Xue X
Mol Cells; 2014 Dec; 37(12):865-72. PubMed ID: 25410907
[TBL] [Abstract][Full Text] [Related]
11. Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice.
Liu R; Zhang X; Fan Z; Wang Y; Yao G; Wan X; Liu Z; Yang B; Yu L
Stem Cell Res Ther; 2019 Oct; 10(1):299. PubMed ID: 31578152
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects.
Huang Y; Zhu M; Liu Z; Hu R; Li F; Song Y; Geng Y; Ma W; Song K; Zhang M
Front Immunol; 2022; 13():997808. PubMed ID: 36389844
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage.
Park HS; Chugh RM; Seok J; Cetin E; Mohammed H; Siblini H; Liakath Ali F; Ghasroldasht MM; Alkelani H; Elsharoud A; Ulin M; Esfandyari S; Al-Hendy A
Stem Cell Res Ther; 2023 Jun; 14(1):165. PubMed ID: 37340468
[TBL] [Abstract][Full Text] [Related]
14. Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency.
Zhang S; Yahaya BH; Pan Y; Liu Y; Lin J
Stem Cell Res Ther; 2023 Nov; 14(1):327. PubMed ID: 37957675
[TBL] [Abstract][Full Text] [Related]
15. Tracking of human embryonic stem cell-derived mesenchymal stem cells in premature ovarian failure model mice.
Bahrehbar K; Khanjarpoor Malakhond M; Gholami S
Biochem Biophys Res Commun; 2021 Nov; 577():6-11. PubMed ID: 34487961
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy.
Bao R; Xu P; Wang Y; Wang J; Xiao L; Li G; Zhang C
Gynecol Endocrinol; 2018 Apr; 34(4):320-326. PubMed ID: 29073798
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure.
He Y; Chen D; Yang L; Hou Q; Ma H; Xu X
Stem Cell Res Ther; 2018 Oct; 9(1):263. PubMed ID: 30286808
[TBL] [Abstract][Full Text] [Related]
18. Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model.
Marchante M; Buigues A; Ramirez-Martin N; Martinez J; Pellicer N; Pellicer A; Herraiz S
Am J Obstet Gynecol; 2023 May; 228(5):561.e1-561.e17. PubMed ID: 36706857
[TBL] [Abstract][Full Text] [Related]
19. Human Bone Marrow Derived-Mesenchymal Stem Cells Treatment for Autoimmune Premature Ovarian Insufficiency.
Ma WQ; Zhuo AP; Xiao YL; Gao M; Yang YT; Tang LC; Wu YH; Tian D; Fu XF
Stem Cell Rev Rep; 2024 Feb; 20(2):538-553. PubMed ID: 38049593
[TBL] [Abstract][Full Text] [Related]
20. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats.
Besikcioglu HE; Sarıbas GS; Ozogul C; Tiryaki M; Kilic S; Pınarlı FA; Gulbahar O
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):53-59. PubMed ID: 30638481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
